These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2206941

  • 1. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
    Siemann DW.
    Br J Cancer; 1990 Sep; 62(3):348-53. PubMed ID: 2206941
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
    Stratford IJ, Adams GE, Godden J, Nolan J, Howells N, Timpson N.
    Br J Cancer; 1988 Aug; 58(2):122-7. PubMed ID: 3166900
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW, Allalunis-Turner MJ.
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [Abstract] [Full Text] [Related]

  • 4. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 5. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA, Siemann DW.
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [Abstract] [Full Text] [Related]

  • 6. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
    Siemann DW, Alliet K, Maddison K, Wolf K.
    Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
    [Abstract] [Full Text] [Related]

  • 8. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW, Beyers KL.
    Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Siemann DW, Sutherland RM.
    Radiother Oncol; 1992 Aug; 24(4):239-45. PubMed ID: 1410579
    [Abstract] [Full Text] [Related]

  • 10. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
    Stratford IJ, Adams GE, Godden J, Howells N.
    Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT, Gipp JJ, Tanner MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
    [Abstract] [Full Text] [Related]

  • 15. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW, Morrissey S, Wolf K.
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [Abstract] [Full Text] [Related]

  • 16. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW, Alliet KL.
    Clin Exp Metastasis; 1987 Apr; 5(1):57-63. PubMed ID: 3829497
    [Abstract] [Full Text] [Related]

  • 18. Bioreductive drugs and the selective induction of tumour hypoxia.
    Bremner JC, Stratford IJ, Bowler J, Adams GE.
    Br J Cancer; 1990 May; 61(5):717-21. PubMed ID: 2110814
    [Abstract] [Full Text] [Related]

  • 19. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW.
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [Abstract] [Full Text] [Related]

  • 20. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC.
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.